Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Filings indexed 477 across all filing types
Latest filing 2018-01-24 Earnings Release
Country CH Switzerland
Listing SW ROSE

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Double-digit growth for the Zur Rose Group in 2017
Earnings Release Classification · 100% confidence The document is a press release dated January 24, 2018, announcing the 'Double-digit growth for the Zur Rose Group in 2017'. It provides key unaudited sales figures for the full year 2017 and the fourth quarter, comparing them to the previous year. This content structure—a brief announcement of preliminary financial performance highlights—is characteristic of an Earnings Release (ER). Crucially, the text explicitly states: 'The Zur Rose Group will publish its full annual report for 2017 on 21 March 2018.' This confirms the current document is the preliminary announcement, not the comprehensive Annual Report (10-K) or the subsequent Audit Report (AR). It is too detailed for a simple Report Publication Announcement (RPA) which usually just points to the report. FY 2017
2018-01-24 English
Opening of more shop-in-shop pharmacies following successful launch
Regulatory Filings Classification · 100% confidence The document is a 'News Details' release dated January 22, 2018, originating from EQS Group News Service, concerning a business cooperation between Migros and Zur Rose Group AG regarding the opening of new shop-in-shop pharmacies. It is structured as a press release announcing a business development and partnership expansion, not a formal regulatory filing like a 10-K, IR, or ER. Since it is a general corporate announcement distributed via a news service (EQS) that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous corporate news releases that are not otherwise classified.
2018-01-22 English
Zur Rose Group: Takeover of Eurapon and Vitalsana successfully concluded
M&A Activity Classification · 100% confidence The document text explicitly announces the successful conclusion of a takeover involving the Zur Rose Group acquiring Eurapon and Vitalsana. This action falls directly under the definition of Merger & Acquisition (M&A) activity. The relevant filing type code is 'TAR' (M&A Activity). The document is a press release detailing the completion of a transaction, not just an announcement of a report being published.
2017-12-29 English
Zur Rose Group focuses on healthcare services in Germany at its Halle location
Regulatory Filings Classification · 100% confidence The document is a press release dated November 27, 2017, announcing a strategic focus change for a subsidiary (Zur Rose Pharma) involving operational restructuring and employee impact. It discusses strategic company decisions, operational changes, and provides contact information for investors and media. This type of announcement, detailing strategic shifts, management decisions, or operational restructuring that doesn't fit neatly into financial reporting (10-K, IR, ER) or specific corporate actions (DIV, CAP), is best classified as a general Regulatory Filing (RNS) or potentially Management Reports (MDA) if it were a more detailed management discussion. Given the format (EQS Group-News) and the nature of the announcement (strategic focus change, employee impact, succession planning), it functions as a broad regulatory disclosure. Since there is no specific category for 'Strategic Company Decision' announcements, and it is not a formal financial report, RNS (Regulatory Filings / General Regulatory Announcements) is the most appropriate fallback category, although it contains elements of management reporting. Given the context of corporate news releases that are not earnings or formal reports, RNS is the standard classification for general disclosures.
2017-11-27 English
Zur Rose-Group acquires mail-order pharmacy Vitalsana
M&A Activity Classification · 99% confidence The document is a press release dated November 23, 2017, announcing that Zur Rose-Group is acquiring another mail-order pharmacy, Vitalsana. The key phrase used is 'Mergers & Acquisitions' (Key word(s): Mergers & Acquisitions). This clearly indicates a transaction related to M&A activity. Therefore, the appropriate classification is 'TAR' (M&A Activity). The document length is relatively short (4001 chars) and it is a direct announcement, not a detailed regulatory filing like a 10-K or a comprehensive report like an IR.
2017-11-23 English
Zur Rose Group speeds up its expansion programme, taking over Eurapon Pharmahandel GmbH
Earnings Release Classification · 100% confidence The document explicitly states it contains 'Significant growth in the third quarter of 2017' and provides detailed sales figures for the 'third quarter' and 'January to September' periods. The keyword 'Quarterly / Interim Statement' is also present. This content structure—detailed financial performance for a period shorter than a full year—is characteristic of an Interim Report (Quarterly Report). It is comprehensive enough to be the report itself, not just an announcement of one. Therefore, the classification is 'Interim / Quarterly Report' (IR). Q3 2017
2017-10-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.